According to a new report, published by KBV research, The Global Bioimpedance Analyzers Market size is expected to reach $1.1 billion by 2030, rising at a market growth of 9.2% CAGR during the forecast period. In the year 2022, the market attained a volume of 3,42,604 Units experiencing a growth of 2.0% (2019-2022).
The Wired segment would experience a CAGR of 8.7% during (2023 - 2030). Wired bioimpedance analyzers are medical devices used to measure and analyze the electrical impedance of biological tissues within the body. Unlike wireless bioimpedance analyzers, which transmit data wirelessly, wired analyzers typically require physical connections, such as cables and electrodes, to perform measurements and transmit data. Wired bioimpedance analyzers typically use a tetrapolar electrode configuration.
The Multi-frequency segment is generating the highest revenue in the Global Bioimpedance Analyzers Market, By Product in 2022; thereby, achieving a market value of $615.9 million by 2030. Multi-frequency bioimpedance analyzers are specialized medical devices that use electrical impedance to measure and analyze the composition and characteristics of biological tissues within the body. Multi-frequency bioimpedance analyzers measure the electrical impedance of tissues at different frequencies.
The Whole-Body Measurement segment is exhibiting a CAGR of 11% during (2023 - 2030). Whole-body measurement application in bioimpedance analyzers involves assessing the electrical impedance of the entire body to obtain comprehensive insights into various physiological parameters, including body composition, fluid distribution, and tissue characteristics. This technique has multiple applications, including healthcare, fitness, sports, nutrition, research, and clinical assessments.
The Professional Grade segment is registering maximum revenue in the Global Bioimpedance Analyzers Market, By Usage Type in 2022; thereby, achieving a market value of $816.2 million by 2030. Professional grade bioimpedance analyzers are advanced medical devices used by healthcare professionals, fitness experts, researchers, and clinicians for precise and detailed assessments of body composition, fluid balance, and tissue characteristics. These analyzers offer a higher level of accuracy and functionality compared to consumer-grade models.
The Hospitals & Clinics segment is experiencing a CAGR of 9.7% during (2023 - 2030). Bioimpedance analyzers are valuable medical devices used in hospitals and clinics for various clinical applications. These analyzers provide information about body composition, fluid balance, and tissue characteristics, helping healthcare professionals make informed patient care and treatment decisions. Patients undergoing hemodialysis or peritoneal dialysis benefited from bioimpedance measurements to assess changes in fluid status and body composition.
The North America region dominated the Global Bioimpedance Analyzers Market, By Region in 2022; thereby, achieving a market value of $380.1 million by 2030. The Europe market is anticipated to grow a CAGR of 8.7% during (2023 - 2030). Additionally, The Asia Pacific market would witness a CAGR of 10% during (2023 - 2030).
Full Report: https://www.kbvresearch.com/bioimpedance-analyzers-market/
The market research report has exhaustive quantitative insights providing a clear picture of the market potential in various segments across the globe with country-wise analysis in each discussed region. The key impacting factors of the market have been discussed in the report with the elaborated company profiles of OMRON Corportion, Tanita Corporation, Inbody Co., Ltd., RJL Systems, SECA GMBH & Co. KG, Maltron International Limited, Selvas Healthcare, Fook Tin Technologies Ltd., Bodystat Ltd. and Charder Electronics Co. Ltd.
By Modality (Volume in Units, USD Million, 2019-2030)
By Product (Volume in Units, USD Million, 2019-2030)
By Application (Volume in Units, USD Million, 2019-2030)
By Usage Type (Volume in Units, USD Million, 2019-2030)
By End User (Volume in Units, USD Million, 2019-2030)
By Geography (Volume in Units, USD Million, 2019-2030)
Companies Profiled
Unique Offerings 
